Connect with us
–Topline efficacy data expected in Q4 2023 – – Preparations are underway to scale the CYB003 program to a potential...
GAINESVILLE, Fla. — Two University of Florida Health researchers have received prestigious High Risk-High Reward grants from the National Institutes...
ATLANTA—An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated...
According to Morningstar's recently-released Biopharma Pipeline Report, the biopharma industry can anticipate a healthy 4.5% in compound annual earnings...
Griffith University’s technology uses a platform approach involving engineered bacterial cells to assemble biopolymer particles coated in an immunogenic...
Locus Robotics, the market leader in autonomous mobile robots (AMR) for fulfillment warehouses, announced its award-winning AMR warehouse automation solution...
Atai Life Sciences has completed its Phase 1 study of VLS-01, an oral DMT for treatment-resistant depression (TRD). The post atai Life Sciences Completes...
OTLK has seen its SMA50 which is now -76.45%. In looking the SMA 200 we see that the stock has seen a -81.04%. RIGL has seen...
BCLI has seen its SMA50 which is now -85.81%. In looking the SMA 200 we see that the stock has seen a -90.24%. AMTX has seen...
HRTX has seen its SMA50 which is now -32.55%. In looking the SMA 200 we see that the stock has seen a -49.46%. ACET has seen...
